单侧肾上腺切除术后原发性醛固酮增多症患者肾素持续抑制与不良结局的关联
该回顾性研究纳入77例因侧化性原发性醛固酮增多症行肾上腺切除术的患者,根据术后约6个月首次随访的直接肾素浓度(DRC)三分位分组(<8、8-16、>16 mU/L),发现DRC<8 mU/L组非典型组织病理和生化缓解不全更常见,但临床结局无差异。
要点
- DRC<8 mU/L组中65.4%仍达到完全生化缓解,临床结局无差异。
核心结论
- 肾上腺切除术后6个月肾素持续抑制常见,与较差的生化结局相关,但与临床结局无关。
研究设计与样本
- 回顾性纳入77例因侧化性原发性醛固酮增多症行肾上腺切除术的患者,均有术后肾素水平。
主要发现
- DRC<8 mU/L组中65.4%达到完全生化缓解。
- 临床结局(靶器官损害和合并症)在各三分位组间无差异。
关键数值与推荐
- 按术后首次随访(约6个月)直接肾素浓度三分位分组:<8 mU/L、8-16 mU/L、>16 mU/L。
- 组织病理采用HISTALDO共识的CYP11B2染色评估。
- 生化及临床结局采用PASO标准评估。
临床怎么用
- 术后6个月肾素持续抑制(DRC<8 mU/L)提示生化缓解可能不全,需加强生化随访。
- 肾素持续抑制未伴随短期临床结局恶化,临床管理可继续按常规进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Suppressed renin concentrations in medically treated patients with primary aldosteronism (PA) are associated with a worse cardiometabolic outcome compared to patients with normalized renin levels. No similar study has been conducted in patients with PA after unilateral adrenalectomy. OBJECTIVE: This study investigates the prevalence and impact of persistent renin suppression after unilateral adrenalectomy in patients with lateralized PA. METHODS: We retrospectively included 77 patients who underwent adrenalectomy for lateralized PA. All patients had postoperative renin levels available. Patients were divided into tertiles based on their direct renin concentrations (DRC) (<8 mU/L, 8-16 mU/L, >16 mU/L) at the first follow-up, approximately 6 months after surgery. Study endpoints included histopathology using CYP11B2 staining according to HISTALDO consensus, biochemical and clinical outcomes according to the PASO criteria and improvement of comorbidities and end-organ damage at short- and long-term follow-up up to 3 years postoperatively. RESULTS: Patients with DRC <8 mU/L showed a higher prevalence of non-classical histopathology compared to the other 2 tertiles (8/26 [30.8%] vs 1/25 [4%] vs 3/26 [11.5%]; P = .024) and more frequently absent or partial biochemical remission at their first follow-up (9/26 [34.6%] vs 3/25 [12.0%] vs 2/26 [7.7%]; P = .036). Nonetheless, 65.4% achieved complete biochemical remission. Clinical outcomes, including end-organ damage and comorbidities, did not differ across the tertiles. CONCLUSION: Persistent renin suppression is common 6 months after adrenalectomy and associated with worse biochemical but not clinical outcomes. More than 60% of patients with DRC <8 mU/L achieved full biochemical remission.
引用
- Stüfchen I, Williams TA, Schweizer JROL, et al. Persistent Renin Suppression After Unilateral Adrenalectomy for Primary Aldosteronism: Implications for Adverse Outcome? J Clin Endocrinol Metab. 2026. PMID: 41175007. doi:10.1210/clinem/dgaf595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。